Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income	$ 200,703	$ 199,098
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	114,837	74,547
Deferred income taxes	30,519	25,955
Loss (gain) on disposition of assets	471	(971)
Share-based compensation	20,941	18,770
Excess tax benefit from share-based compensation	(1,958)	(3,401)
Non-cash interest expense	1,396	1,090
Non-cash increase in contingent consideration	913	1,016
(Increase) decrease in:
Receivables, net	(32,576)	(67,244)
Inventories	(197,836)	(105,739)
Other current assets	(38,602)	(9,938)
Pre-production and development costs	(33,266)	(6,684)
(Decrease) increase in:
Accounts payable	(21,130)	133,728
Accrued warranties	4,819	23,405
Accrued other liabilities	39,714	(10,870)
Income taxes payable	(50,711)	(2,101)
Net change in derivative assets and liabilities	(11,320)	(35,213)
Other operating activities	(7,143)	(11,467)
Net cash provided by operating activities	19,771	223,981
Cash flows from investing activities:
Acquisitions, net of cash received	(619)	(4,220)
Capital expenditures	(87,352)	(62,759)
Proceeds from asset dispositions	50	4,548
Other items, net	1,042	286
Net cash used in investing activities	(86,879)	(62,145)
Cash flows from financing activities:
Increase (decrease) in short-term borrowings	340	(1,682)
Repayments of long-term debt	(26,259)	(141,875)
Cash dividends to shareholders	(50,172)	(45,927)
Repurchase of common stock	(50,009)	0
Exercise of stock options	5,527	10,406
Repurchases related to share-based compensation arrangements	(11,861)	(21,924)
Excess tax benefit from share-based compensation	1,958	3,401
Payment of contingent consideration	(327)	(327)
Other items, net	(2,310)	859
Net cash used in financing activities	(133,113)	(197,069)
Effect of exchange rate changes on cash	(11,756)	(35,817)
Net (Decrease) in cash and cash equivalents	(211,977)	(71,050)
Cash and cash equivalents at beginning of period	649,513	581,312
Cash and cash equivalents at end of period	437,536	510,262
Supplemental disclosure of cash flow information:
Interest paid, net	10,736	4,313
Income taxes paid	45,851	8,284
Non-cash investing activities:
Accrued and contingent acquisition-related liabilities	$ 914	$ 8,603